Literature DB >> 25660347

Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Pavlo Gilchuk1, Timothy M Hill2, John T Wilson3, Sebastian Joyce4.   

Abstract

Once a burgeoning field of study, over the past decade or so, T cell epitope discovery has lost some luster. The contributory factors perchance are the general notion that any newly discovered epitope will reveal very little about an immune response and that knowledge of epitopes are less critical for vaccine design. Despite these notions, the breadth and depth of T cell epitopes derived from clinically important microbial agents of human diseases largely remain ill defined. We review here a flurry of recent reports that have rebirthed the field. These reports reveal that epitope discovery is an essential step toward rational vaccine design and critical for monitoring vaccination efficacy. The new findings also indicate that neither immunogenicity nor immunodominance predict protective immunity. Hence, an immunogenic epitope is but a peptide unless proven protective against disease.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25660347      PMCID: PMC5023008          DOI: 10.1016/j.coi.2015.01.013

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  73 in total

1.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

Authors:  W Chen; L C Antón; J R Bennink; J W Yewdell
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  T cell killing does not require the formation of a stable mature immunological synapse.

Authors:  Marco A Purbhoo; Darrell J Irvine; Johannes B Huppa; Mark M Davis
Journal:  Nat Immunol       Date:  2004-03-28       Impact factor: 25.606

3.  Identification of classical minor histocompatibility antigen as cell-derived peptide.

Authors:  H J Wallny; H G Rammensee
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

4.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

5.  Toward a human vaccines project.

Authors:  Wayne C Koff; Ian D Gust; Stanley A Plotkin
Journal:  Nat Immunol       Date:  2014-07       Impact factor: 25.606

6.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

7.  HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Authors:  Rachid Boucherma; Hédia Kridane-Miledi; Romain Bouziat; Michael Rasmussen; Tanja Gatard; Francina Langa-Vives; Brigitte Lemercier; Annick Lim; Marion Bérard; Lbachir Benmohamed; Søren Buus; Ronald Rooke; François A Lemonnier
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

8.  Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones.

Authors:  A E Campbell; F L Foley; S S Tevethia
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

9.  Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance.

Authors:  Maya F Kotturi; Iain Scott; Tom Wolfe; Bjoern Peters; John Sidney; Hilde Cheroutre; Matthias G von Herrath; Michael J Buchmeier; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

10.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more
  12 in total

Review 1.  Proteomic contributions to our understanding of vaccine and immune responses.

Authors:  Allison C Galassie; Andrew J Link
Journal:  Proteomics Clin Appl       Date:  2015-09-10       Impact factor: 3.494

2.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

3.  In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.

Authors:  Julien Schmidt; Philippe Guillaume; Danijel Dojcinovic; Julia Karbach; George Coukos; Immanuel Luescher
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

Review 4.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

5.  Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Authors:  Charles T Spencer; Jelena S Bezbradica; Mireya G Ramos; Chenoa D Arico; Stephanie B Conant; Pavlo Gilchuk; Jennifer J Gray; Mu Zheng; Xinnan Niu; William Hildebrand; Andrew J Link; Sebastian Joyce
Journal:  Proteomics Clin Appl       Date:  2015-12       Impact factor: 3.494

6.  PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination.

Authors:  Arash Memarnejadian; Courtney E Meilleur; Christopher R Shaler; Khashayarsha Khazaie; Jack R Bennink; Todd D Schell; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-09-22       Impact factor: 5.422

Review 7.  Constant regulation for stable CD8 T-cell functional avidity and its possible implications for cancer immunotherapy.

Authors:  Connie B Gilfillan; Michael Hebeisen; Nathalie Rufer; Daniel E Speiser
Journal:  Eur J Immunol       Date:  2021-03-30       Impact factor: 5.532

8.  Discordant rearrangement of primary and anamnestic CD8+ T cell responses to influenza A viral epitopes upon exposure to bacterial superantigens: Implications for prophylactic vaccination, heterosubtypic immunity and superinfections.

Authors:  Courtney E Meilleur; Arash Memarnejadian; Adil N Shivji; Jenna M Benoit; Stephen W Tuffs; Tina S Mele; Bhagirath Singh; Jimmy D Dikeakos; David J Topham; Hong-Hua Mu; Jack R Bennink; John K McCormick; S M Mansour Haeryfar
Journal:  PLoS Pathog       Date:  2020-05-20       Impact factor: 6.823

9.  Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.

Authors:  Rafaela Holtappels; Niels A W Lemmermann; Jürgen Podlech; Stefan Ebert; Matthias J Reddehase
Journal:  Front Immunol       Date:  2016-06-14       Impact factor: 7.561

Review 10.  CD8 + T-cell responses in vaccination: reconsidering targets and function in the context of chronic antigen stimulation.

Authors:  Gabriela Cosma; Laurence Eisenlohr
Journal:  F1000Res       Date:  2018-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.